Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (3,201,187)	$ 14,618,450
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(58,394)	(32,084)
Realized investment gains, net	(8,953,840)	(6,415,476)
Change in fair value of equity securities	11,738,163	(14,884,779)
Amortization of cost of insurance acquired	372,425	387,953
Depreciation	239,510	594,399
Stock-based compensation	218,289	246,534
Charges for mortality and administration of universal life and annuity products	(3,164,512)	(3,235,159)
Interest credited to account balances	2,012,606	2,052,343
Change in accrued investment income	151,566	140,588
Change in reinsurance receivables	646,537	338,491
Change in policy liabilities and accruals	(2,219,077)	(1,317,789)
Change in income taxes receivable (payable)	472,319	(25,242)
Change in other assets and liabilities, net	(3,142,189)	2,842,382
Net cash used in operating activities	(4,887,784)	(4,689,389)
Proceeds from investments sold and matured:
Fixed maturities available for sale	12,253,350	4,566,651
Equity securities	16,186,805	4,939,893
Mortgage loans	230,116	4,381,319
Real estate	3,418,671	10,687,242
Notes receivable	3,333,296	1,827,987
Policy loans	713,241	930,639
Short-term investments	6,000,000	0
Total proceeds from investments sold and matured	42,135,479	27,333,731
Cost of investments acquired:
Fixed maturities available for sale	(9,038,928)	(2,507,805)
Equity securities	(10,286,666)	(115,013)
Trading securities	0	(132,518)
Mortgage loans	(5,098,138)	(4,014,455)
Real estate	0	(1,408,021)
Notes receivable	(3,500,000)	(7,528,188)
Policy loans	(618,465)	(705,906)
Short-term investments	(7,890,228)	0
Total cost of investments acquired	(36,432,425)	(16,411,906)
Net cash provided by investing activities	5,703,054	10,921,825
Cash flows from financing activities:
Policyholder contract deposits	2,283,017	2,410,517
Policyholder contract withdrawals	(2,118,404)	(2,756,026)
Purchase of treasury stock	(450,057)	(561,342)
Non controlling contributions (distributions) of consolidated subsidiary	0	(245,750)
Net cash used in financing activities	(285,444)	(1,152,601)
Net increase in cash and cash equivalents	529,826	5,079,835
Cash and cash equivalents at beginning of period	28,787,629	20,150,162
Cash and cash equivalents at end of period	$ 29,317,455	$ 25,229,997